{"paper_id":"31411047-dd9e-4315-8a47-25ebb27a65c7","body_text":"Received\n 03/16/2024 \nReview began\n 03/16/2024 \nReview ended\n 03/21/2024 \nPublished\n 03/26/2024\n© Copyright \n2024\nDantkale et al. This is an open access\narticle distributed under the terms of the\nCreative Commons Attribution License CC-\nBY 4.0., which permits unrestricted use,\ndistribution, and reproduction in any\nmedium, provided the original author and\nsource are credited.\nA Comprehensive Review of the Diagnostic\nLandscape of Endometriosis: Assessing Tools,\nUncovering Strengths, and Acknowledging\nLimitations\nKetki S. Dantkale \n, \nManjusha Agrawal \n1.\n Obstetrics and Gynecology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and\nResearch, Wardha, IND\nCorresponding author: \nKetki S. Dantkale, \nketkidantkale24@gmail.com\nAbstract\nEndometriosis is a prevalent yet often underdiagnosed condition characterized by the presence of\nendometrial-like tissue outside the uterus, leading to significant morbidity and impaired quality of life. A\ntimely and accurate diagnosis of endometriosis is essential for effective management and improved patient\noutcomes. This review provides a comprehensive overview of the current diagnostic landscape of\nendometriosis, including clinical evaluation, imaging modalities, biomarkers, and laparoscopy. The\nstrengths and limitations of each diagnostic approach are critically evaluated, alongside challenges such as\ndelayed diagnosis and misinterpretation of findings. The review emphasizes the importance of\nmultidisciplinary collaboration, standardized diagnostic protocols, and ongoing research to enhance\ndiagnostic accuracy and facilitate early intervention. By addressing these challenges and leveraging\nemerging technologies, healthcare professionals can improve the diagnosis and management of\nendometriosis, ultimately enhancing the well-being of affected individuals.\nCategories:\n Internal Medicine, Medical Education\nKeywords:\n multidisciplinary collaboration, laparoscopy, imaging, biomarkers, diagnosis, endometriosis\nIntroduction And Background\nEndometriosis is a chronic, often painful condition characterized by the growth of endometrial-like tissue\noutside the uterus, commonly affecting the pelvic organs such as the ovaries, fallopian tubes, and\nperitoneum \n[1]\n. This ectopic tissue responds to hormonal fluctuations during the menstrual cycle, leading to\ninflammation, scarring, and the formation of adhesions. Endometriosis affects approximately 10% of\nreproductive-aged individuals and is a leading cause of infertility and debilitating pelvic pain \n[2]\n.\nA timely and accurate diagnosis of endometriosis is paramount due to its significant impact on the physical,\nemotional, and social well-being of affected individuals. Delayed diagnosis often results in prolonged\nsuffering, impaired quality of life, and increased healthcare costs. Moreover, early identification of\nendometriosis allows for the prompt initiation of appropriate management strategies, including pain relief,\nfertility preservation, and disease monitoring \n[3]\n.\nThis review aims to comprehensively evaluate the diagnostic landscape of endometriosis, assessing the\nstrengths and limitations of existing tools and techniques. This review seeks to inform clinicians,\nresearchers, and policymakers about the challenges and opportunities in improving diagnostic accuracy and\npatient care by synthesizing current knowledge and emerging trends in endometriosis diagnosis.\nReview\nCurrent diagnostic tools\nClinical History and Physical Examination\nThe clinical history and physical examination play a pivotal role in diagnosing endometriosis. Patients with\nendometriosis typically exhibit symptoms such as heavy menstrual bleeding (menorrhagia), painful\nmenstruation (dysmenorrhea), irregular uterine bleeding (metrorrhagia), persistent pelvic discomfort, and\npain during sexual intercourse (dyspareunia). Furthermore, a history of multiple pregnancies or previous\nuterine surgeries may be noted, with infertility occasionally linked to adenomyosis, particularly as more\nwomen postpone childbearing \n[2,4]\n. During the physical examination, indicators suggest endometriosis\nencompasses an immobile retroverted uterus, palpable nodules on the uterosacral ligaments, and a cul-de-\nsac exhibiting narrowing of the posterior fornix. The presence of an enlarged, tender, and \"boggy\" uterus\noften points towards adenomyosis, whereas severe endometriosis is frequently characterized by a fixed,\ntender uterus with discernible nodules in specific regions \n[5]\n. Variations in physical examination findings\n1\n1\n \n Open Access Review\nArticle\n \nDOI:\n 10.7759/cureus.56978\nHow to cite this article\nDantkale K S, Agrawal M (March 26, 2024) A Comprehensive Review of the Diagnostic Landscape of Endometriosis: Assessing Tools, Uncovering\nStrengths, and Acknowledging Limitations. Cureus 16(3): e56978. \nDOI 10.7759/cureus.56978\n\ncan be significant, contingent upon the location of endometriotic lesions. For instance, speculum\nexamination may only reveal lesions in a subset of patients, while indicators such as profound dyspareunia\nand nodules in the pouch of Douglas merit careful consideration \n[6]\n.\nDiagnostic Imaging\nImaging techniques play a pivotal role in the diagnosis of endometriosis. Transvaginal ultrasound (TVS) and\nmagnetic resonance imaging (MRI) stand out as the primary imaging modalities utilized for preoperative\nassessment and precise identification of endometriosis lesions \n[6,7]\n. These techniques are indispensable for\ndiscerning various types of endometriotic lesions, encompassing superficial endometriosis, deep\nendometriosis, and ovarian endometriosis, each demanding tailored imaging approaches for accurate\ndiagnosis \n[7,8]\n. Moreover, advanced imaging methodologies such as multidetector computed tomography\nenema and computed tomography colonography have been investigated to detect bowel endometriosis,\noffering comprehensive visualization of the bowel wall and aiding in the differentiation from other\nconditions such as cancer or inflammatory diseases \n[7]\n. Although TVS typically serves as the frontline\nimaging modality owing to its accessibility and cost-effectiveness, MRI assumes particular significance in\ndiagnosing deep infiltrating endometriosis (DIE), notably in regions like neural endometriosis, where\nultrasound depiction may be insufficient \n[8,9]\n.\nBiomarkers and Laboratory Tests\nBiomarkers serve as vital components in the diagnosis of endometriosis, providing valuable insights into the\npresence and severity of the disease. These biomolecules encompass diverse substances, including proteins,\ngenes, lipids, RNA, DNA, enzymes, and hormones, reflecting endometriosis's physiological state or\ncondition \n[10]\n. While certain individual biomarkers, like CA-125, have been extensively investigated, their\ndiagnostic accuracy may be limited when utilized in isolation. Research indicates that combining multiple\nbiomarkers can enhance diagnostic precision, with certain studies achieving an area under the curve (AUC)\nranging from 0.71 to 0.81 for discriminating endometriosis from control subjects \n[11,12]\n. Despite sustained\nresearch endeavors to identify reliable biomarkers for endometriosis detection, the quest for a singular\nclinically dependable biomarker still needs to be discovered. The field actively explores emerging\ntechnologies such as \"omics\" approaches, molecular imaging techniques, and microRNAs to bolster\ndiagnostic capabilities \n[13]\n. The pursuit of specific diagnostic biomarkers continues to advance, focusing on\ninnovative molecular biology methodologies and diverse monitoring modalities to refine the detection and\nmanagement of endometriosis.\nLaparoscopy: Gold Standard for Diagnosis\nLaparoscopy is the gold standard for diagnosing endometriosis, enabling direct visualization of the disease.\nThis minimally invasive surgical technique involves the insertion of a fiber optic camera into the patient's\npelvis, facilitating the inspection of internal structures, identification of abnormal tissue areas, and biopsy\ncollection to confirm endometriosis through microscopic examination by a pathologist \n[14]\n. While other\ndiagnostic modalities such as imaging studies (MRI, CT, and ultrasound) and medical history may suggest\nthe presence of endometriosis, laparoscopy remains the sole definitive method for accurate diagnosis \n[14]\n.\nStudies have demonstrated that laparoscopic visualization exhibits high sensitivity (90.1%) and moderate\nspecificity (40.0%) compared to histopathology, the gold standard for diagnosis, underscoring its efficacy in\ndetecting endometriotic lesions \n[15]\n. Despite its invasive nature, laparoscopy confirms the diagnosis and\nenables concurrent treatment by surgically excising diseased areas, rendering it an integral component of\ncomprehensive care for patients suspected of endometriosis \n[14]\n.\nAssessing diagnostic accuracy\nSensitivity and Specificity of Diagnostic Tools\nThe sensitivity and specificity of diagnostic tools for identifying endometriosis are critical for an accurate\ndiagnosis. Different symptoms and physical examination findings exhibit varying levels of sensitivity and\nspecificity in diagnosing endometriosis. Pain exacerbations during menstruation and infertility demonstrate\na sensitivity of 20.37% and a specificity of 97.87%. In comparison, symptoms such as intensified menstrual\npain and irregular periods present a sensitivity of 75.93% and a specificity of 51.06% \n[16]\n. These findings\nunderscore the importance of considering a combination of symptoms and examination results to enhance\ndiagnostic precision. Machine learning algorithms (MLA) have emerged as a novel screening approach for\nendometriosis, showing promising sensitivity and specificity values ranging from 0.82 to 1 in diagnosing the\ncondition \n[17]\n. Furthermore, self-report symptom-based prediction models have exhibited high sensitivity\n(75%) and specificity (69%) in predicting endometriosis, with the most effective model achieving an AUC of\n0.94 \n[4]\n. Integrating a combination of symptoms, physical examination findings, and innovative approaches\nsuch as MLA and self-report tools can enhance the sensitivity and specificity of diagnostic tools for\nendometriosis. This integrated approach can facilitate more precise and timely condition identification \n[16-\n18]\n.\n2024 Dantkale et al. Cureus 16(3): e56978. DOI 10.7759/cureus.56978\n2\n of \n8\n\nChallenges in Diagnosis: Delay and Misdiagnosis\nDiagnosing endometriosis presents multifaceted challenges, resulting in delays and misdiagnoses. A\nsignificant obstacle lies in the diverse manifestations of the disease, rendering small lesions challenging to\ndetect without specific diagnostic tools \n[19]\n. Moreover, the nonspecific nature of endometriosis symptoms,\nsuch as pelvic pain, heavy menstrual bleeding, and dyspareunia, overlaps with those of other gynecological\nand gastrointestinal conditions, further complicating the diagnostic journey \n[20]\n. The absence of reliable\nscreening tools exacerbates the challenge, as conventional imaging techniques like ultrasound and MRI may\nnot suffice for effective endometriosis detection \n[20]\n. Furthermore, the normalization of menstrual pain and\na general lack of awareness or education about female health contribute to symptom dismissal or\nunderestimation, leading to delayed or missed diagnoses \n[20]\n. This delay in diagnosis, averaging between 7\nand 11 years, significantly impacts women's mental health, quality of life, and overall well-being \n[19]\n.\nAdditionally, inflammation surrounding abnormal endometrial tissue can complicate the biopsy process,\npotentially obscuring the microscopic structure necessary for an accurate diagnosis \n[21]\n. The complexity of\nendometriosis symptoms, coupled with the absence of specific diagnostic tools and the normalization of\nmenstrual pain, pose substantial challenges in diagnosing the condition, often resulting in delays and\nmisdiagnoses that profoundly affect women's health and quality of life \n[19-21]\n.\nPatient Perspectives on Diagnostic Experiences\nPatient perspectives on diagnostic experiences are crucial for comprehending the intricacies of the\ndiagnostic process. Studies have delved into the interactions and communication dynamics between\nhealthcare providers and patients during diagnostic imaging investigations, shedding light on the\nimportance of patient-centered care and effective communication throughout the diagnostic journey \n[22]\n.\nPatient experiences within diagnostic pathways, such as those observed in lung cancer diagnosis, reveal\nheightened levels of anxiety associated with fast-track programs, highlighting the necessity for support,\ninformation dissemination, and the involvement of relatives to navigate through the diagnostic process\neffectively \n[23]\n. Moreover, research has assessed the impact of various strategies for communicating\ndiagnostic uncertainty on patient perceptions of physician competence. Effectively communicating\ndiagnostic uncertainty can foster patient engagement in the diagnostic process and mitigate delays in\nseeking appropriate care, thus underscoring the significance of clear and empathetic communication\nbetween physicians and patients, particularly during uncertain diagnostic scenarios \n[24]\n.\nStrengths of existing diagnostic approaches\nAdvantages of Laparoscopy\nLaparoscopic surgery offers several advantages over traditional open surgery, making it a preferred choice for\nmany patients and surgeons. Firstly, laparoscopic procedures involve smaller incisions, resulting in less\ntrauma to the body and minimal scarring \n[25,26]\n. These smaller incisions also contribute to a lower risk of\ncomplications such as infection, blood loss, and swelling, as laparoscopic tools enable precise and complex\nprocedures with reduced trauma to healthy tissues \n[25]\n. Additionally, the minimally invasive nature of\nlaparoscopic surgery leads to reduced postoperative pain and faster recovery times compared to traditional\nopen surgery \n[25]\n. Furthermore, patients undergoing laparoscopic surgery often experience shorter hospital\nstays due to the minimally invasive nature of the procedure and the faster healing process \n[27]\n. Moreover,\nlaparoscopy is a versatile procedure used for diagnostic and surgical interventions for various conditions,\nsuch as endometriosis, fibroids, ovarian cysts, hysterectomy, and more \n[27]\n. Another significant advantage\nof laparoscopy is improved visualization, which provides surgeons with in-depth and realistic insight into\nbody organs and allows for precise and accurate procedures \n[28]\n. Additionally, laparoscopic surgery is\nconsidered an economical procedure, with benefits including minimum side effects, less internal scarring,\nand a higher success rate compared to traditional open surgery methods \n[28]\n. Overall, these advantages\nhighlight the significant benefits of laparoscopic surgery for patients and healthcare providers alike. The\nadvantages of laparoscopy are shown in Figure \n1\n.\n2024 Dantkale et al. Cureus 16(3): e56978. DOI 10.7759/cureus.56978\n3\n of \n8\n\nFIGURE\n 1: Advantages of laparoscopy\nImage Credit: Corresponding Author\nRole of Imaging in Screening and Preoperative Assessment\nImaging is pivotal in screening and preoperative assessment across various medical conditions. In\nendometriosis, imaging techniques such as CT scans have proven beneficial in preoperative planning for\npatients with isolated nasal obstruction and septal deviation. A retrospective study underscored the\nsignificant contribution of CT imaging in modifying the initial surgical plan based on physical examination\nfindings in most cases, highlighting the importance of imaging in surgical decision-making for such\nconditions \n[29]\n. Similarly, in the assessment and surgical treatment of breast cancer, preoperative magnetic\nMRI has been instrumental in detecting additional diseases, determining disease extent, and guiding\nsurgical decisions. The utilization of preoperative MRI has been correlated with enhanced detection rates\nand a more comprehensive understanding of disease extent, thereby facilitating treatment planning and\ndecision-making for patients with breast cancer \n[30]\n.\nEmerging Biomarkers and Their Potential\nEmerging biomarkers for endometriosis, including CA-125, CA-199, urocortin, and IL-6, hold promise for\ndetecting the condition \n[13]\n. However, despite their potential, these biomarkers still need to meet the\ncriteria for diagnostic biomarkers due to various limitations in their utility and accuracy \n[13]\n. Additionally,\ncirculating endometrial cells have been identified as having significant potential for developing an early,\nnon-invasive diagnostic assay for endometriosis \n[13]\n. The integration of these promising biomarkers with\nemerging molecular diagnostic technologies has the potential to unveil new biomarkers for endometriosis in\nperipheral blood, uterine materials, or urine \n[13]\n. While individual biomarkers like CA-125 have undergone\nextensive study, a panel of multiple markers will likely offer greater accuracy than any single biomarker in\ndiagnosing endometriosis \n[13]\n. Further research and validation are imperative to establish clinically reliable,\nnon-invasive tests for endometriosis detection and to enhance patient outcomes \n[31]\n.\nLimitations and areas for improvement\nInvasiveness and Risks Associated With Laparoscopy\nLaparoscopy is a minimally invasive surgical procedure widely used to diagnose and treat endometriosis.\nAlthough generally safe and effective, laparoscopy carries potential risks, including internal bleeding, hernia\nformation at incision sites, infection, and inadvertent damage to blood vessels or other organs such as the\nbladder or bowels. Patients may experience post-surgical pain, swelling, or redness and should promptly\nseek medical attention if they develop a fever or severe symptoms. While most individuals can return home\nshortly after the procedure, some may necessitate a hospital stay, depending on the complexity of the\n2024 Dantkale et al. Cureus 16(3): e56978. DOI 10.7759/cureus.56978\n4\n of \n8\n\nsurgery \n[32]\n. Compared to traditional open surgeries like laparotomy, laparoscopy is less invasive. It offers\nsuperior visualization of endometriosis lesions, typically leading to shorter hospital stays and quicker\nrecovery times. However, despite its advantages, laparoscopy primarily targets visible lesions, which may\nnot address all aspects of endometriosis-related pain. Additionally, complications such as symptom\nrecurrence, scarring, injuries to adjacent organs like the bladder or bowel, and the requirement for multiple\nsurgeries may arise in some cases. The efficacy of laparoscopic surgery in alleviating symptoms varies among\npatients, with some individuals experiencing persistent pain even after lesion removal \n[32,33]\n.\nChallenges in Interpreting Imaging Findings\nInterpreting imaging findings for endometriosis presents unique challenges that necessitate expertise and\nexperience. Pelvic MRI for endometriosis, in particular, poses a diagnostic challenge requiring a specific skill\nset and experience due to the intricate nature of the disease presentation. While MRI is highly accurate for\ndiagnosing DIE, the interpretation of MRI results hinges on the radiologist's proficiency in imaging\ntechniques and comprehension of specific MRI findings \n[8]\n. The challenges in interpreting imaging findings\nfor endometriosis are further compounded by the subtle manifestations of the disease, which can be\noverlooked or mistaken for other conditions. Consequently, patients often encounter delayed diagnosis,\nleading to misdiagnosis and adversely affecting their quality of life. Radiologists play a pivotal role in\nfacilitating early and accurate diagnosis through MRI, providing detailed reports that assist in treatment\nplanning and ultimately improve patient outcomes \n[8]\n.\nReliability and Standardization of Biomarkers\nThe reliability and standardization of biomarkers for diagnosing endometriosis are critical factors that\ndirectly influence their effectiveness in clinical practice. Despite numerous studies aiming to identify non-\ninvasive biomarkers for this condition, challenges persist due to variabilities in study design, a lack of\nconsensus on the disease's pathophysiology, and the absence of specific symptoms, leading to delayed\ndiagnosis. The gold standard for diagnosing endometriosis remains invasive surgery followed by\nhistopathological examination, underscoring the urgent need for more reliable and standardized non-\ninvasive biomarkers \n[12,13,34]\n. The research underscores the importance of developing biomarker panels\nrather than relying on single biomolecules for diagnosing endometriosis. While various biomolecules hold\npromise, they must demonstrate the requisite sensitivity and specificity for accurate diagnosis. Utilizing\nmultiple biomarkers or a combination of different non-invasive diagnostic methods will likely enhance the\nreliability of diagnosing endometriosis. Future advancements in omics technology and immunoassay\ntechniques offer the potential for discovering more valuable biomarker panels, emphasizing the necessity for\nstandardized and reliable biomarkers to diagnose endometriosis \n[13]\n.\nSocioeconomic and Cultural Barriers to Accessing Diagnosis\nSocioeconomic and cultural barriers exert a significant influence on accessing timely diagnosis for\nendometriosis. Research underscores disparities in access to care, diagnosis, treatment, and management of\nendometriosis among various racial and socioeconomic groups in the United States. Studies reveal that non-\nWhite women encounter challenges in receiving appropriate care, with Black women experiencing elevated\nrates of perioperative complications, mortality, and prolonged perioperative stages compared to other racial\nand ethnic groups. These disparities underscore the imperative for further research to address diagnostic\nand treatment gaps beyond surgical management and socioeconomic hurdles \n[35,36]\n. Cultural factors also\nhave a crucial impact on delayed diagnosis, as societal perceptions of womanhood and menstruation may\nnormalize symptoms, impeding healthcare providers' recognition of endometriosis. Furthermore, the stigma\nsurrounding menstruation and the misconception that endometriosis primarily affects white, middle-class\nwomen contribute to diagnostic biases and inadequate care for individuals from diverse racial and ethnic\nbackgrounds. These cultural beliefs, coupled with socioeconomic inequities, erect substantial barriers to\naccessing proper diagnosis and treatment for endometriosis, underscoring the necessity of addressing these\nissues to enhance healthcare equity and outcomes for all individuals affected by the condition \n[37]\n.\nFuture directions in endometriosis diagnosis\nAdvances in Non-invasive Diagnostic Techniques\nAdvancements in non-invasive diagnostic techniques for various skin disorders, including psoriasis and\npigmentary skin disorders, have enhanced diagnostic accuracy and patient comfort. These innovations\nencompass a spectrum of imaging techniques such as dermoscopy, high-frequency ultrasound, multispectral\nimaging, optical coherence tomography, reflectance confocal microscopy, and more. By offering detailed\ninsights into skin properties in vivo, these methods facilitate the definitive diagnosis and therapeutic\nmonitoring of conditions like psoriasis \n[38,39]\n. Moreover, non-invasive diagnostic modalities like\ndermoscopy, ultrasonography, confocal laser microscopy, and reflectance spectrophotometers have yielded\npromising results in diagnosing pigmentary skin disorders and cutaneous cancers. These techniques provide\na comfortable and objective means to monitor disease progression and deliver accurate diagnoses without\nnecessitating invasive procedures such as skin biopsies \n[38]\n.\n2024 Dantkale et al. Cureus 16(3): e56978. DOI 10.7759/cureus.56978\n5\n of \n8\n\nIntegration of Artificial Intelligence in Diagnostic Algorithms\nIntegrating artificial intelligence (AI) into diagnostic algorithms revolutionizes healthcare by significantly\nenhancing diagnostic precision, streamlining administrative tasks, and personalizing treatment plans. AI\nalgorithms, particularly machine learning methods like deep learning, are employed to analyze medical data\nand images from various modalities such as X-rays, MRIs, CT scans, and ultrasound. These algorithms excel\nat identifying patterns and abnormalities that may be challenging for human practitioners to detect,\nresulting in more accurate and efficient diagnoses \n[40-43]\n. In medical imaging analysis, AI has successfully\ndetected diseases, such as breast cancer, and identified lung nodules. It offers superior pattern recognition\ncapabilities, consistency, speed, and the ability to rapidly process vast volumes of data. Additionally, AI is\nmaking strides in pathology by automating workflow processes in pathology labs and enhancing accuracy in\ntissue sample analysis and cancer diagnoses. Powered by AI, predictive diagnostics utilize patient data to\nforecast health risks and personalize risk assessments for diseases like diabetes and heart attacks \n[42]\n.\nMoreover, AI's impact extends to treatment planning through personalized medicine, accelerated drug\ndevelopment, and robot-assisted surgery. In personalized medicine, AI tailors treatment plans based on\ngenetic profiles, lifestyle factors, and health conditions. It interprets genetic data to predict disease\npredispositions and responses to treatments. In drug development, AI expedites the discovery process by\nefficiently analyzing biological and chemical data, predicting drug interactions, reducing development\ncosts, improving clinical trials, and identifying new applications for existing drugs \n[42]\n.\nPersonalized Medicine Approaches\nPersonalized medicine approaches in endometriosis entail tailoring treatment based on individual patient\npreferences and genetic characteristics to enhance patient outcomes. These approaches consider factors\nsuch as patient preferences for treatment attributes and genetic variations contributing to the disease. For\ninstance, a study implemented a personalized medicine approach to determine individualized drug doses for\nendometriosis patients, taking into account patient preferences for the safety and efficacy attributes of the\nmedication. This involved simulating weighted attributes representing various patient profiles and adjusting\ndrug dosages accordingly \n[44]\n. Additionally, PrecisionLife has acquired the Oxford Endometriosis Gene\n(OXEGENE) dataset from the University of Oxford to develop personalized treatments for endometriosis\npatients. PrecisionLife aims to identify genetic disparities among individuals with endometriosis and\nelucidate the underlying mechanisms driving the disease by analyzing genetic data obtained from surgically\nconfirmed patients. This initiative endeavors to expedite reaching a personalized diagnosis and develop\nnovel treatments by correlating biomarkers with patient-specific genetic profiles \n[45]\n.\nImportance of Multidisciplinary Collaboration\nMultidisciplinary collaboration is pivotal in managing endometriosis, particularly in intricate cases like DIE.\nA multidisciplinary team approach involves specialists such as endometriosis surgeons, colorectal surgeons,\nurologists, radiologists, pain specialists, and psychologists collaborating to deliver optimal patient care. This\ncollaborative approach ensures higher-quality decision-making, standardized patient care, and improved\noutcomes. Research indicates that a multidisciplinary approach enhances pain management, improves\nquality of life post-treatment, and improves patient outcomes in severe endometriosis cases \n[46,47]\n. The\nadvantages of multidisciplinary collaboration extend beyond individual expertise by promoting cross-\ndiscipline learning, research, and review. This approach is crucial for addressing the complexity of\nendometriosis management and ensuring that patients receive comprehensive and evidence-based care. By\nbringing together specialists from diverse fields, a multidisciplinary team can devise personalized treatment\nplans, enhance postoperative outcomes, and provide holistic support to patients navigating endometriosis's\nphysical, mental, and emotional challenges \n[46,47]\n.\nConclusions\nThis review has provided a comprehensive assessment of the diagnostic landscape of endometriosis,\nhighlighting the strengths and limitations of current approaches. From clinical evaluation to advanced\nimaging and biomarker research, each method offers valuable insights into diagnosing this debilitating\ncondition. Despite advancements, challenges such as delayed diagnosis and variability in diagnostic\naccuracy persist, necessitating collective action to improve detection and management. This requires\nincreased awareness among healthcare providers and the public, investment in research for novel diagnostic\nmodalities, and the implementation of standardized protocols in clinical practice. By fostering collaboration\nacross disciplines and advocating for improved diagnostic strategies, we can enhance early detection,\nstreamline patient care, and ultimately improve outcomes for individuals affected by endometriosis.\nAdditional Information\nAuthor Contributions\nAll authors have reviewed the final version to be published and agreed to be accountable for all aspects of the\nwork.\n2024 Dantkale et al. Cureus 16(3): e56978. DOI 10.7759/cureus.56978\n6\n of \n8\n\nConcept and design:\n  \nKetki S. Dantkale, Manjusha Agrawal\nAcquisition, analysis, or interpretation of data:\n  \nKetki S. Dantkale, Manjusha Agrawal\nDrafting of the manuscript:\n  \nKetki S. Dantkale, Manjusha Agrawal\nCritical review of the manuscript for important intellectual content:\n  \nKetki S. Dantkale, Manjusha\nAgrawal\nSupervision:\n  \nKetki S. Dantkale, Manjusha Agrawal\nDisclosures\nConflicts of interest:\n In compliance with the ICMJE uniform disclosure form, all authors declare the\nfollowing: \nPayment/services info:\n All authors have declared that no financial support was received from\nany organization for the submitted work. \nFinancial relationships:\n All authors have declared that they have\nno financial relationships at present or within the previous three years with any organizations that might\nhave an interest in the submitted work. \nOther relationships:\n All authors have declared that there are no\nother relationships or activities that could appear to have influenced the submitted work.\nAcknowledgements\nI want to express my deep appreciation for the integral role of artificial intelligence (AI) tools like\nGrammarly, Paperpal, and ChatGPT in completing this research paper. The ChatGPT language model\n(OpenAI, San Francisco, California) was employed to assist in the formulation of key arguments, structuring\nthe content, and refining the language of our manuscript. It provided valuable insights and suggestions\nthroughout the writing process, enhancing the overall coherence and clarity of the article. It was also utilized\nto assist in editing and rephrasing the work to ensure coherence and clarity in conveying the findings.\nReferences\n1\n. \nSmolarz B, Szyłło K, Romanowicz H: \nEndometriosis: epidemiology, classification, pathogenesis, treatment\nand genetics (review of literature)\n. Int J Mol Sci. 2021, 22:10554. \n10.3390/ijms221910554\n2\n. \nTsamantioti ES, Mahdy H: \nEndometriosis\n. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL);\n2023.\n3\n. \nParasar P, Ozcan P, Terry KL: \nEndometriosis: epidemiology, diagnosis and clinical management\n. Curr Obstet\nGynecol Rep. 2017, 6:34-41. \n10.1007/s13669-017-0187-1\n4\n. \nAllaire C, Bedaiwy MA, Yong PJ: \nDiagnosis and management of endometriosis\n. CMAJ. 2023, 195:363-71.\n10.1503/cmaj.220637\n5\n. \nBradley LD: \nIndications and contraindications for office hysteroscopy\n. Hysteroscopy. Bradley LD, Falcone T\n(ed): \nMosby, Philadelphia; 2009. 1016:19-38. \n10.1016/B978-032304101-0.50009-6\n6\n. \nRiazi H, Tehranian N, Ziaei S, Mohammadi E, Hajizadeh E, Montazeri A: \nClinical diagnosis of pelvic\nendometriosis: a scoping review\n. BMC Womens Health. 2015, 15:39. \n10.1186/s12905-015-0196-z\n7\n. \nGuerriero S, Ajossa S, Pagliuca M, et al.: \nAdvances in imaging for assessing pelvic endometriosis\n.\nDiagnostics (Basel). 2022, 12:2960. \n10.3390/diagnostics12122960\n8\n. \nLorusso F, Scioscia M, Rubini D, et al.: \nMagnetic resonance imaging for deep infiltrating endometriosis:\ncurrent concepts, imaging technique and key findings\n. Insights Imaging. 2021, 12:105. \n10.1186/s13244-021-\n01054-x\n9\n. \nQuesada J, Härmä K, Reid S, et al.: \nEndometriosis: a multimodal imaging review\n. Eur J Radiol. 2023,\n158:110610. \n10.1016/j.ejrad.2022.110610\n10\n. \nPant A, Moar K, K Arora T, Maurya PK: \nBiomarkers of endometriosis\n. Clin Chim Acta. 2023, 549:117563.\n10.1016/j.cca.2023.117563\n11\n. \nIrungu S, Mavrelos D, Worthington J, Blyuss O, Saridogan E, Timms JF: \nDiscovery of non-invasive\nbiomarkers for the diagnosis of endometriosis\n. Clin Proteomics. 2019, 16:14. \n10.1186/s12014-019-9235-3\n12\n. \nAnastasiu CV, Moga MA, Elena Neculau A, et al.: \nBiomarkers for the noninvasive diagnosis of\nendometriosis: state of the art and future perspectives\n. Int J Mol Sci. 2020, 21:1750. \n10.3390/ijms21051750\n13\n. \nTian Z, Chang XH, Zhao Y, Zhu HL: \nCurrent biomarkers for the detection of endometriosis\n. Chin Med J\n(Engl). 2020, 133:2346-52. \n10.1097/CM9.0000000000001063\n14\n. \nLaparoscopic Diagnosis\n. (2014). Accessed: March 16, 2024: \nhttps://www.vitalhealth.com/endometriosis-\nspecialty-center/endometriosis-surgery/laparoscopic-diagnosis/\n.\n15\n. \nGratton SM, Choudhry AJ, Vilos GA, et al.: \nDiagnosis of endometriosis at laparoscopy: a validation study\ncomparing surgeon visualization with histologic findings\n. J Obstet Gynaecol Can. 2022, 44:135-41.\n10.1016/j.jogc.2021.08.013\n16\n. \nNawrocka-Rutkowska J, Szydłowska I, Rył A, Ciećwież S, Ptak M, Starczewski A: \nEvaluation of the diagnostic\naccuracy of the interview and physical examination in the diagnosis of endometriosis as the cause of\nchronic pelvic pain\n. Int J Environ Res Public Health. 2021, 18:6606. \n10.3390/ijerph18126606\n17\n. \nBendifallah S, Puchar A, Suisse S, et al.: \nMachine learning algorithms as new screening approach for\npatients with endometriosis\n. Sci Rep. 2022, 12:639. \n10.1038/s41598-021-04637-2\n18\n. \nGoldstein A, Cohen S: \nSelf-report symptom-based endometriosis prediction using machine learning\n. Sci Rep.\n2023, 13:5499. \n10.1038/s41598-023-32761-8\n19\n. \nDiagnostic Challenges of Endometriosis\n. (2023). Accessed: March 16, 2024:\nhttps://www.contemporaryobgyn.net/view/diagnostic-challenges-of-endometriosis\n.\n2024 Dantkale et al. Cureus 16(3): e56978. DOI 10.7759/cureus.56978\n7\n of \n8\n\n20\n. \nThe Challenges of Diagnosing Endometriosis\n. (2023). Accessed: March 16, 2024:\nhttps://www.patientclaimline.com/expert-information/the-challenges-of-diagnosing-endometriosis/\n.\n21\n. \nDiagnosing Endometriosis\n. (2023). Accessed: March 16, 2024:\nhttps://www.yalemedicine.org/conditions/diagnosing-endometriosis\n.\n22\n. \nMakanjee CR, Bergh AM, Hoffmann WA: \nHealthcare provider and patient perspectives on diagnostic imaging\ninvestigations\n. Afr J Prim Health Care Fam Med. 2015, 7:801. \n10.4102/phcfm.v7i1.801\n23\n. \nChristensen HM, Huniche L: \nPatient perspectives and experience on the diagnostic pathway of lung cancer:\na qualitative study\n. SAGE Open Med. 2020, 8:2050312120918996. \n10.1177/2050312120918996\n24\n. \nBhise V, Meyer AN, Menon S, Singhal G, Street RL, Giardina TD, Singh H: \nPatient perspectives on how\nphysicians communicate diagnostic uncertainty: an experimental vignette study\n. Int J Qual Health Care.\n2018, 30:2-8. \n10.1093/intqhc/mzx170\n25\n. \nConsider These 5 Benefits of Laparoscopy\n. (2023). Accessed: March 16, 2024:\nhttps://www.obgynassociatesmarietta.com/blog/consider-these-5-benefits-of-laparoscopy\n.\n26\n. \nLaparoscopy\n. (2022). Accessed: March 16, 2024: \nhttps://my.clevelandclinic.org/health/procedures/4819-\nlaparoscopy\n.\n27\n. \nLaparoscopic Surgery: Risks, Benefits, and Recovery\n. (2023). Accessed: March 16, 2024:\nhttps://www.goodrx.com/health-topic/procedures/laparoscopic-surgery\n.\n28\n. \nLim S, Ghosh S, Niklewski P, Roy S: \nLaparoscopic Suturing as a Barrier to Broader Adoption of Laparoscopic\nSurgery\n. JSLS. 2017, 21:2017.00021. \n10.4293/JSLS.2017.00021\n29\n. \nCarmel-Neiderman NN, Safadi A, Wengier A, et al.: \nThe role of imaging in the preoperative assessment of\npatients with nasal obstruction and septal deviation-a retrospective cohort study\n. Int Arch\nOtorhinolaryngol. 2021, 25:242-8. \n10.1055/s-0040-1712933\n30\n. \nGoodrich ME, Weiss J, Onega T, et al.: \nThe role of preoperative magnetic resonance imaging in the\nassessment and surgical treatment of interval and screen-detected breast cancer in older women\n. Breast J.\n2016, 22:616-22. \n10.1111/tbj.12651\n31\n. \nHerranz-Blanco B, Daoud E, Viganò P, García-Velasco JA, Colli E: \nDevelopment and validation of an\nendometriosis diagnostic method based on serum biomarkers and clinical variables\n. Biomolecules. 2023,\n13:1052. \n10.3390/biom13071052\n32\n. \nWhat Is Laparoscopic Surgery for Endometriosis?\n. (2022). Accessed: March 16, 2024:\nhttps://www.webmd.com/women/endometriosis/laparoscopic-surgery\n.\n33\n. \nWhat to Expect From a Laparoscopy for Endometriosis\n. (2023). Accessed: March 16, 2024:\nhttps://www.medicalnewstoday.com/articles/322469\n.\n34\n. \nDolińska W, Draper H, Othman L, et al.: \nAccuracy and utility of blood and urine biomarkers for the\nnoninvasive diagnosis of endometriosis: a systematic literature review and meta-analysis\n. F&S Rev. 2023,\n4:116-30. \n10.1016/j.xfnr.2022.12.001\n35\n. \nWestwood S, Fannin M, Ali F, et al.: \nDisparities in women with endometriosis regarding access to care,\ndiagnosis, treatment, and management in the United States: a scoping review\n. Cureus. 2023, 15:38765.\n10.7759/cureus.38765\n36\n. \nThe Endometriosis Resource Portal for People of Color\n. (2021). Accessed: March 16, 2024:\nhttps://www.endofound.org/the-endometriosis-resource-portal-for-people-of-color\n.\n37\n. \nVoices of Endo: cultural factors influencing delayed diagnosis of endometriosis\n. (2023). Accessed: March 16,\n2024: \nhttps://scholarship.claremont.edu/cgi/viewcontent.cgi?article=1590&context=cgu_etd\n.\n38\n. \nPathania YS, Apalla Z, Salerni G, Patil A, Grabbe S, Goldust M: \nNon-invasive diagnostic techniques in\npigmentary skin disorders and skin cancer\n. J Cosmet Dermatol. 2022, 21:444-50. \n10.1111/jocd.14547\n39\n. \nLacarrubba F, Pellacani G, Gurgone S, Verzì AE, Micali G: \nAdvances in non-invasive techniques as aids to\nthe diagnosis and monitoring of therapeutic response in plaque psoriasis: a review\n. Int J Dermatol. 2015,\n54:626-34. \n10.1111/ijd.12870\n40\n. \nUndru TR, Uday U, Lakshmi JT, et al.: \nIntegrating artificial intelligence for clinical and laboratory diagnosis -\na review\n. Maedica (Bucur). 2022, 17:420-6. \n10.26574/maedica.2022.17.2.420\n41\n. \nMilan L: \nArtificial intelligence and machine learning in integrated diagnostic\n. Integrated diagnostics and\ntheranostics of thyroid diseases. Giovanella L (ed): Springer, Cham; 2023. 5-11. \n10.1007/978-3-031-35213-\n3_2\n42\n. \nArtificial Intelligence in Healthcare: Revolutionising Diagnosis and Treatment\n. (2024). Accessed: March 16,\n2024: \nhttps://openmedscience.com/artificial-intelligence-in-healthcare-revolutionising-diagnosis-and-\ntreatment/\n.\n43\n. \nKaralis VD: \nThe integration of artificial intelligence into clinical practice\n. Appl Biosci. 2024, 3:14-44.\n10.3390/applbiosci3010002\n44\n. \nWinzenborg I, Soliman AM, Shebley M: \nA personalized medicine approach using clinical utility index and\nexposure-response modeling informed by patient preferences data\n. CPT Pharmacometrics Syst Pharmacol.\n2021, 10:40-7. \n10.1002/psp4.12570\n45\n. \nPrecisionLife Licenses University of Oxford Data to Discover Personalised Treatments for Endometriosis\nPatients\n. (2024). Accessed: March 16, 2024: \nhttps://www.wrh.ox.ac.uk/news/precisionlife-licenses-\nuniversity-of-oxford-data-to-discover-personalised-treatments-fo...\n.\n46\n. \nYour Multidisciplinary Treatment Team for Endometriosis\n. (2021). Accessed: March 16, 2024:\nhttps://drseckin.com/your-multidisciplinary-treatment-team-for-endometriosis/\n.\n47\n. \nWhy Your Endometriosis Treatment Plan Should be Multidisciplinary\n. (2021). Accessed: March 16, 2024:\nhttps://icarebetter.com/multidisciplinary-team-approach-endometriosis-treatment/\n.\n2024 Dantkale et al. Cureus 16(3): e56978. DOI 10.7759/cureus.56978\n8\n of \n8","source_license":"CC0","license_restricted":false}